Scientists urged to break the thought silos

Scientists urged to break the thought silos

Scientists urged to break the thought silos

Crossing disciplinary boundaries is unusual – and crucially important. In 1998, groundbreaking thinker and eminent biologist EO Wilson cautioned against scientific overspecialization, warning that thought silos “…must be torn down in order for humanity to progress.” Sociobiologist Rebecca Costa argued in 2010 that “the more fortified and numerous silos become, the further away humankind strays from a unified, systemic approach to our greatest threats.”

The big problems we face today demand interdisciplinary innovation. Look no further than the international climate talks in Paris for an example of an issue that must be approached by individuals with deep disciplinary expertise but also from an interdisciplinary perspective. Big ideas come from understanding the big picture and making cross-boundary connections, not only from eking out incremental advances in an esoteric subfield.

Not surprisingly, universities, research organizations and funding agencies of all stripes – keenly aware of the enormous potential of cross-disciplinary collaboration – enthusiastically tout their support for all things interdisciplinary. Think of nanotechnology, which draws on physics, biology and chemistry. Or disease control efforts that rely on public health officials, behavioral scientists, biostatisticians and epidemiologists.

Deep and broad research approaches both have advantages and disadvantages. So why do people in different scientific specialties so rarely engage in meaningful collaborative projects? My collaborator Andrew Hess and I recently investigated scientists’ goals and work styles with an eye toward the depth versus breadth of their research output.

What do funders value in grant proposals? Ohio Sea Grant, CC BY-NC

What do funders value in grant proposals? Ohio Sea Grant, CC BY-NC

Sure it’s structural, but people can choose

Amidst the calls for boundary-spanning collaboration, the fact is that most scientists work within institutional and professional contexts that overwhelmingly favor and reward deep specialization. Consider the names of departments and journals, how communications flow within rather than across unit boundaries, and how pay and grant monies are allocated. For some, the word“generalist” is pejorative, but collaborating across disciplines does not need to be a bad thing. In fact, in one survey of faculty, 70% agreed with the value of cross-disciplinary work.

Beyond structural determinants, what are the personal drivers that shape the depth versus breadth of researchers’ professional output? While investigating this question, Andrew Hess and I defined deep research as that which adds to our knowledge in highly specialized ways. We defined broad research as that which spans a greater variety of topics.

How much impact can research have if it’s just an incremental advance in a super-specific discipline? US Army Africa, CC BY

How much impact can research have if it’s just an incremental advance in a super-specific discipline? US Army Africa, CC BY

How our researchers rated depth versus breadth

In our first study, we provided medical researchers with descriptions of two hypothetical studies. One was deeply specialized; the other was broad and boundary-spanning. Both had relevance to the participants’ expertise, and we said they were fully funded. We asked them to rate the attractiveness of the two studies along dimensions including risk, significance of opportunity, potential importance and so on.

The results were clear: all else being equal, the broader study was seen as representing a riskier and less significant opportunity, of lower potential import. Respondents were less likely to follow up on the interdisciplinary research. Forced to choose, two-thirds of the researchers said they’d pursue the deeper over the broader study.

Fundamentally, these scientists saw boundary-crossing research as offering high levels of professional risk with low rewards and only meager professional returns.

Output reflects mindset

In the next study, we collected questionnaire data from 466 medical researchers about their goals and outlooks. Then we compared their responses with archival data that allowed us to objectively assess the depth and breadth of their 10-year publication portfolios. The questionnaires provided useful insights into key work-related behaviors and attitudes, including such traits as competitiveness and conscientiousness.

We were able to relate the researchers’ behaviors and mindsets, as reflected in their questionnaire scores, to the breadth and depth of their published research. It turned out that researchers’ goalspredicted the depth versus the breadth of their publication portfolios.

Researchers who were strongly motivated to demonstrate high performance (performance goal orientation) exhibited more depth over a decade of research, but not more breadth. The opposite – more breadth, and not more depth – held for those who reported great interest in trying and learning new things, even if doing so would prove costly in terms of time and professional advancement (high learning goal orientation).

This finding makes sense when you consider that performance is often judged by publications in highly specialized journals that advance knowledge in a researcher’s specific subfield. One would have to be driven to learn new things, perhaps at significant cost, in order to willingly buck the expectation and go for a broader approach that isn’t often rewarded. Research doesn’t happen by structural fiat; it’s also driven by what the individual scientist finds intrinsically appealing and rewarding.

Our scientist participants also differed in the extent to which they focused their efforts on exploiting their current knowledge versus exploring for new knowledge. By default, scientists tend to capitalize on existing specialized expertise.

Management theory and research make it clear that individuals and organizations both tend to favor the safer exploitation of current knowledge over exploration. All else equal, it’s more efficient and less frustrating to refine a previous finding. It’s tough to shift gears and investigate an altogether new question on a different topic requiring new learning, and likely mistakes, along a longer path to a publication. The unintended result, of course, is that the potential boundary-pushing benefits of exploration remain unrealized.

To tackle big problems, we need to work across disciplines. During the Paris climate talks, people walk amid ice imported from Greenland. Benoit Tessier/Reuters

To tackle big problems, we need to work across disciplines. During the Paris climate talks, people walk amid ice imported from Greenland. Benoit Tessier/Reuters

Ready for a change

Here’s an important point, with big implications: the behaviors we observed are not necessarily indicative of deeply ingrained personality traits. They’re just styles of work that can be changed if individuals choose to change them. Once scientists become aware of what their tendencies are, they can start to think strategically about how they might alter them. By changing how they allocate time, effort and resources, researchers can strive for greater breadth (or depth) in future projects.

Some companies – including Apple, Unilever and the Cleveland Clinic – work hard to break down silo thinking and want their professionals and managers to be “T-shaped.” The vertical in the T is a specialty. The crossbar represents knowledge of other specialties, and/or, crucially, experience and skills in working creatively and effectively with people in different areas. For example, researchers Uhlenbrook and de Jong describe T-shaped competency profiles using water professionals – hydrologists, hydraulic engineers, land use specialist, water economists and water governance experts – who all need to collaborate, valuing each other’s expertise and willingly crossing subspecialty borders.

Our study looked at individual research behaviors and output. But the implications of those individual actions are nothing short of global. The tremendous value of research characterized by finely honed specialization and depth is undeniable. But as global events – including the climate change talks in Paris – daily remind us, it’s only through effective collaboration and meaningful disciplinary boundary crossing that we will find solutions to the massive and complex challenges facing the world today.

The author, Thomas Bateman, is Professor of Management, University of Virginia. This article was originally published in The Conversation under a Creative Commons Attribution No Derivatives license. You can read the original article here.

Article originally posted by , Posted on: December 10, 2015 at: http://scitechconnect.elsevier.com/scientists-superspecialize-change/

7

Updates direct to your Email

Enter your email address to receive notifications of new posts and opportunities by email.

Join 7,243 other subscribers

Post categories

Cost-effective rabies prevention strategy

Cost-effective rabies prevention strategy

Cost-effective rabies prevention strategy

Mass dog vaccination is the most cost-effective way to control rabies and decrease human deaths. from the figure below it is clear that with a higher vaccination coverage of the dog population there are multiple benefits, in terms of: (1) reduction in number of human mortalities (2) cost savings in terms of expenditure on treatment and control (3) healthier dogs and humans and everyone is happy 🙂

Costeffective Rabies control

Originally posted on twitter by @OIE

7

Updates direct to your Email

Enter your email address to receive notifications of new posts and opportunities by email.

Join 7,243 other subscribers

Post categories

Cats Get Breast Cancer Too, and There’s a Lot We Can Learn From It

Cats Get Breast Cancer Too, and There’s a Lot We Can Learn From It

Cats Get Breast Cancer Too, and There’s a Lot We Can Learn From It

Understanding aggressive tumors in pets may lead to better treatments for the nastiest forms of the disease in people

Felix seems determined to test the idea that cats have nine lives. I adopted him as a kitten from someone whose outdoor cat got unexpectedly pregnant. When I took him for his first vet visit, he was riddled with parasites, from ear mites to intestinal worms. A medley of kitty drugs eventually cleaned him up with no lasting effects. At age five he burrowed through the screen door on my balcony and took a dive, falling six stories and collapsing a lung. That required X-rays, an overnight stay in an oxygen tank and another round of meds

Then, in January, I found a lump on his chest, close to his right front paw. Hours of web searches and an initial vet visit both came to the same conclusion: my male cat potentially had breast cancer.

Cat cancer is something I was already painfully familiar with. My other cat Sally had developed a lump in her cheek three years ago at age 16, and I spent a lot of time taking her for test after test before I finally got the grim diagnosis. She had oral squamous cell carcinoma, and it was basically inoperable. This particular cancer is fairly common in cats but notoriously aggressive, with a 1-year survival rate of less than 10 percent. In the end, all the ultrasounds, oncologist visits and desperate attempts to feed her via syringe didn’t help, and she died within a few months.

With that nightmare experience still fresh in my mind, Felix’s lump became an obsession. This time, I was going to fight for the earliest possible diagnosis and treatment. My morbid curiosity also kicked into high gear, especially as I saw so many quizzical looks when I said, “… and they think it might be breast cancer.” What, exactly, was happening to my cat?

It turns out that, beyond surgery options, the study of mammary cancer in cats suffers from a dearth of coordinated clinical research. But a coalition of vets and doctors will soon be gathering in Washington, D.C., to help build the case that better understanding of canine and feline tumors could be a huge benefit to dealing with the disease not just in pets, but maybe also in people.

###

It’s no medical surprise that cats can get mammary cancer. Cats of both genders have eight mammary glands, with four along either side of their tummies. Even if you find only a single lump, when a biopsy comes back cancer, the usual recommended action is to remove the entire chain on that side. According to Felix’s vet, the four glands are connected to lymphatic vessels that can transport cancer cells through the body, so doing a radical mastectomy is the best way to be sure you cut out the problem. Some vets even advise removing the chains on both sides, just to be safe.

Because of the lymphatic connection, vets will often check whether the nearby lymph nodes show any abnormalities, and some will go ahead and remove those too during a mastectomy. Our vet also suggested we do a lung X-ray before any kind of surgery, because that’s a common spot cancer will spread from the mammary chain. Once it’s in the lungs, things get dire, and some vets will say you should consider cancelling surgery and moving instead to kitty hospice care. If the cat is cleared for a surgical procedure, all that’s left is to wait and hope.

“Surgery is usually all we do to provide treatment for a primary tumor,” says veterinary oncologist Karin Sorenmo at the University of Pennsylvania. “In women, we offer breast-sparing surgery, because that is important for women psychologically.” That leaves some breast tissue in place but requires the patient to go through follow-up doses of radiation or chemotherapy to beat back any lingering cancer cells and reduce the odds of recurrence. “Cats and dogs are different that way—they don’t have self-image issues if we do a big surgery,” she says. Giving a cat radiation therapy also means putting it back under anesthesia, which carries its own risks. “It’s better to get it all out.”

The disease is most common in older breeding females. “The risk for developing breast cancer overall is dependent on exposure to hormones,” says Sorenmo. “There’s a seven-fold increase in risk in cats that have not been spayed, and spaying has to occur at a very early age if you’re going to have the best benefit.” Sorenmo says she has seen mammary cancers in male cats too, more often if they have been taking hormone therapies like progesterone-based drugs for behavioral problems such as spraying or aggression.

If Felix had a tumor, he would simply be unlucky. He was spayed as a young cat and has had no behavioral problems (or at least ones serious enough to require medication—he is a cat, after all). One vet told me we could start with antibiotics and then see how the lump evolved; if it was a cyst or some type of infection, it might go away on its own. But while this type of cancer is extremely rare in males, in general feline mammary tumors are malignant 86 percent of the time. In other words, if Felix’s lump was a tumor, it was most likely a really bad one.

###

The aggressive nature of mammary cancer in cats is part of what intrigues Sorenmo the most, and one of the reasons she and other experts think finding out more about the feline version could be a boon to humans. According to the National Cancer Institute, the number of new human breast cancer cases has been stable for the past 10 years, but the number of deaths has actually been on the decline, going down by 1.9 percent on average each year from 2002 to 2011. Thanks to early detection efforts, doctors are finding more breast tumors while they are still localized and the cancer has not spread into other regions of the body. Surgery and drug options are improving too, and today 98.5 percent of people who are diagnosed with localized breast cancer are still alive at least five years later. But the situation can be much worse for people who are in more advanced stages or who have particularly nasty forms of the disease.

In healthy human breast tissue, the cells have receptors that relay messages from the hormones progesterone and estrogen, which help the cells grow and function. About 40 percent of the time, breast cancer cells have these hormone receptors too, which is actually a good thing, because it means they usually respond to hormone-based treatments that can direct the cancerous cells to slow down or even stop growing. Sometimes, though, breast cancer is double negative, meaning it lacks these receptors. Triple-negative breast cancer is missing both hormone receptors and the receptor for a protein called HER2, another target of drug therapies. These cancers are tougher to treat and quick to spread.

“When cats develop mammary cancer, it is much more malignant, similar to double- or triple-negative cancers in women,” says Rodney Page at the Flint Animal Cancer Center at Colorado State University. If the tumor is small and hasn’t spread to the lymphatic system or the lungs, surgery is often very successful, he says. “Beyond surgery, chemotherapy has been tried the most, and there are some cancer chemo-therapeutics for cats that have been studied. But we don’t have large clinical studies that show they are successful. The situation in cats is going to require some new thinking. It’s an opportunity to identify new strategies.”

For a lot of human cancer studies today, researchers induce tumors in animals such as mice to develop new drugs and to figure out the environmental and genetic underpinnings. But Sorenmo and Page, among others, think that looking to feline or canine cancer might offer a unique advantage to basic research.

“Cancer is cancer, whether it appears in a golden retriever or a human,” says Page. “Pets live in the same households as their owners and are exposed to the same volatile organic compounds or whatever else the exposure looks like.” That means pets that develop the disease are ideal subjects for teasing out the long-term triggers in people too, and new therapies developed to prevent or treat cancer in companion animals could be similarly useful for humans.

“Dogs and cats live such shorter periods of time, and many of their biological processes happen so much faster, so we can get answers to some questions much quicker,” says Sorenmo. Because cats and dogs have multiple mammary glands in a chain, it’s even possible for tumors of various stages to appear together, offering a chance to simultaneously see how a tumor develops and grows.

In June, Page will be speaking at a workshop put together by the Institute of Medicine of the National Academies, which will bring together human and veterinary oncologists to assess the status of research and figure out how they can better collaborate. Right now about 20 academic centers in the U.S., including Colorado State, conduct clinical trials for cancers in pets and examine how their findings can relate back to people, under the umbrella of the National Cancer Institute’s Comparative Oncology consortium. For instance, Page and his colleagues are about to wrap up a nationwide lifetime study of cancer in 3,000 golden retrievers, a dog breed that is at especially high risk for various types of the disease.

“This isn’t a new philosophy; certainly this type of comparative research has been going on for decades,” David Vail, a veterinarian at the University of Wisconsin-Madison, told the News in Health NIH newsletter last May. “But, it’s probably been just in the last 10 years that clinical trials involving pets have become well-organized.”

The trick now is to put the latest trials to good use in human cancer efforts in both academia and industry. “We conduct clinical studies with the same consent and rigor that occur in people. We also worry about pain management and how to help control nausea, vomiting and diarrhea,” says Page. “But there is an issue of awareness—a large portion of the population doesn’t necessarily think there is a connection. Plus there’s the funding issue of how to convince the NIH or corporate drug manufacturers that these are valuable investments to accelerate the pace of finding cures.”

Sorenmo agrees: “It all falls into this concept that there are many species, but the diseases we have at the molecular level are very similar, and the flow of information should go both ways,” she says.

###

As with people, dogs and cats have the best chance of survival if cancer is caught early. This can be especially problematic for cats, which are in the habit of masking pain and other ill effects as a survival tactic. As much as I beat myself up about Sally’s death, she took her sweet time letting me know she had a tumor—she acted normally until her lump affected her eating, and by then there wasn’t much either surgery or drugs could do. I only noticed Felix’s lump because the 13-pound fluff ball likes to be carried around the house like a prince in a palanquin, and my hand accidentally landed on just the right spot.

Page recommends a more proactive approach, like doing regular physical exams for various cancer types—”any vet can show you how”—and getting into the habit of recording changes in the animal’s skin, from dark spots to scabs to lumps. Sorenmo adds that you should make sure to rub your cat’s belly and gently squeeze the mammary glands, even if it means getting some indignant swipes in return. “Cats sometimes have their own opinion about what they will allow you to do, but it can make a big difference,” she says.

Despite my eagerness to get Felix on a treatment path as soon as possible, I opted for a biopsy first, just to be sure. A radical mastectomy would have involved cutting him open from armpit to back leg, while a biopsy would just be a tiny incision near the nipple to remove the mass for lab tests. I was somewhat comforted by the fact that the lump was loose and unchanging, and that his risk was so low.

Happily, Felix was just fine. I almost collapsed from relief when I got the call saying his lump was a benign cyst, and it was small enough that they had gotten the whole thing out during the biopsy. The worst he had to endure was a small scar, a few loopy days on pain meds and a week in the cone of shame. This is totally normal, says Page. Older animals get lumps and bumps, and in many cases it’s nothing serious. But it’s still worth going through the effort to find out, he says: “Sometimes it’s not so benign.” And maybe in the near future, your vet visit will be helping to save the lives of people as well as pets.

This article originally appeared on the Smithsonian website.

7

Updates direct to your Email

Enter your email address to receive notifications of new posts and opportunities by email.

Join 7,243 other subscribers

Post categories

One health genomics- why animal diseases matter for human health

One health genomics- why animal diseases matter for human health

One health genomics- why animal diseases matter for human health

…At the PHG Foundation, a science and health policy think tank, we have been examining policy issues surrounding the prospective implementation of pathogen genomic technologies in the UK health service. Our most recent briefing note is titled “One health genomics- why animal diseases matter for human health”. The briefing outlines some potential benefits and considerations of human and animal health agencies conducting coordinated pathogen genomic surveillance. We thought the briefing might be of interest to you [the One Health Initiative team] given the remit of your organisation. …

Please see entire briefing note at http://www.phgfoundation.org/briefing_notes/422/

In humans, pathogen genomics is beginning to improve diagnosis of infections, tracking of outbreaks and identification of antimicrobial resistance. Could a cross-species (‘one health’) approach, to include similar efforts with animals, benefit both animal and human populations?

  • Animals are the source of around 75% of newly emerging human infectious diseases
  • The use of antibiotics to treat bacterial infections in livestock means that if these infections are transmitted to humans they may already be resistant to many of the antibiotics we use to treat them
  • Epidemiological analyses to trace the transmission between animal populations and / or between animal and humans are rarely conducted
  • Pathogen whole genome sequencing (WGS) has several advantages over conventional methods for diagnosing pathogen infections and characterising outbreaks, namely rapid diagnosis, high sensitivity, and flexible analysis
  • Implementing a genomic cross-species surveillance (one health) would enable earlier detection of pathogens and their transmission within and between species
  • Wider policy issues surrounding the prospective implementation of pathogen genomics in a clinical and public health context are detailed in our report Pathogen Genomics Into Practice

And a further blog here: http://www.phgfoundation.org/blog/16913/.  Further information on the wider “Pathogen genomics into practice project” can be found here: http://www.phgfoundation.org/project/id.

This article was originally posted at the One Health News section of the onehealthinitiative website.

7

Updates direct to your Email

Enter your email address to receive notifications of new posts and opportunities by email.

Join 7,243 other subscribers

Post categories

Humans carry more antibiotic-resistant bacteria than animals they work with

Humans carry more antibiotic-resistant bacteria than animals they work with

Humans carry more antibiotic-resistant bacteria than animals they work with

Antibiotic-resistant bacteria are a concern for the health and well-being of both humans and farm animals. One of the most common and costly diseases faced by the dairy industry is bovine mastitis, a potentially fatal bacterial inflammation of the mammary gland (IMI). Widespread use of antibiotics to treat the disease is often blamed for generating antibiotic-resistant bacteria. However, researchers investigating staphylococcal populations responsible for causing mastitis in dairy cows in South Africa found that humans carried more antibiotic-resistant staphylococci than the farm animals with which they worked. The research is published in the Journal of Dairy Science®

Animal agriculture is often blamed for generating antibiotic-resistant bacteria through the “widespread” use of antibiotics. “South Africa has one of the highest HIV/AIDS and tuberculosis rates in the world and the human health risk to immune-compromised individuals is therefore that much greater,” explained lead investigator Tracy Schmidt, a PhD candidate at the Department of Medical Microbiology, University of Pretoria, and a veterinary researcher at the KwaZulu-Natal (KZN) provincial Department of Agriculture and Rural Development in South Africa. “The rise of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) and reported cases of bacterial transmission between dairy cows and humans has raised concerns from both the agriculture/veterinary sector and public health officials. The lack of data about the occurrence of LA-MRSA in South Africa and the need to investigate possible reservoirs were part of the motivation for this work.”

Staphylococcus aureus is a contagious udder pathogen that readily spreads between cows at milking. The main source is milk from infected quarters, with milking machine teat liners playing a significant role in the transmission of the bacteria among cows and mammary quarters. Infected cows need to be promptly identified and appropriate control measures need to be taken to curb bacterial transmission among cows. Other Staphylococcus species, collectively referred to as coagulase-negative staphylococci (CNS), have traditionally been regarded as opportunistic pathogens of minor importance as mastitis caused by these bacteria is usually mild and remains subclinical However, the significance of CNS is being reassessed because, in many countries including South Africa, CNS have become the most common bacteria isolated from bovine IMI. Also of great importance is the fact that CNS often exhibit extensive resistance to antimicrobials and may serve as a reservoir of resistance genes that can transfer and supplement the genome of more pathogenic bacteria like Staphylococcus aureus.

This research in the KwaZulu-Natal province of South Africa investigated the diversity of Staphylococcus populations responsible for IMI in dairy cows and assessed the susceptibility of different species to antimicrobials commonly used in the veterinary field as well as human medicine. At the same time, individuals working in close contact with the animals were sampled and the diversity and susceptibility profiles of staphylococcal isolates determined and compared with isolates of animal origin.

With respect to staphylococcal diversity the results showed the clear predominance of Staphylococcus chromogenes among the CNS causing IMI, while Staphylococcus epidermidis was the isolate most commonly recovered from the human specimens.

The study found a relatively low occurrence of antimicrobial resistance among the bovine staphylococci. “This is encouraging as it indicates the responsible usage of antimicrobials within local dairies and provides our veterinary practitioners and animal owners valuable information going forward with respect to the treatment of infected animals,” commented Schmidt. None of the staphylococcal isolates of bovine origin were found to be resistant to methicillin. Furthermore, all isolates tested negative for the presence of vancomycin-encoding genes — vancomycin being one of the front-line antimicrobials used for the treatment of methicillin-resistant staphylococcal infections in humans. The results indicate the low potential health risk posed to close contact workers and milk consumers through exposure to antibiotic-resistant staphylococci originating from milk.

“Of greatest interest was the extensive antimicrobial resistance noted among the coagulase-negative staphylococci of human origin. Multidrug resistance was common among isolates, and due to the propensity for staphylococci to acquire antimicrobial resistance through genetic exchange, human staphylococci can be regarded as a potential reservoir of resistance genes,” added Schmidt.

“As an industry we are making great strides to reduce the use of blanket treatment of farm animals with antibiotics and the notion that antibiotic-resistant bacteria are moving from farm animals to humans has been debunked many times,” observed Matt Lucy, PhD, Professor of Animal Science at the University of Missouri and Editor-in-Chief of the Journal of Dairy Science. “What the authors found is that the humans working with farm animals carry far more antibiotic-resistant staphylococci that the farm animals they work with. The risk, therefore, is the transfer from humans to farm animals and not from farm animals to humans as is often suggested.”

This article originally appeared on the sciencedaily website.

7

Updates direct to your Email

Enter your email address to receive notifications of new posts and opportunities by email.

Join 7,243 other subscribers

Post categories

Dolphin health is connected to human well-being

Dolphin health is connected to human well-being

Dolphin health is connected to human well-being

Dolphins are known to marine biologists as sentinel animals, if they are ailing, we humans may be next. The Indian River Lagoon, an ecologically diverse estuary that covers 40 percent of Florida’s east coast, is ailing. The area is home to a large human population who live near its shores and plays a significant part in the area’s economy. The lagoon’s nitrogen-saturated waters—due to fertilizer run-off and other pollution—is likely promoting the algae blooms that are toxic to marine mammals and birds.

4. DolphinsFlorida Institute of Technology assistant professor Spencer Fire and researchers from lead agency Georgia Aquarium and other conservation partners recently completed a study to better understand the health of Atlantic bottlenose in the IRL, and the data collected from the dolphins is expected to help researchers understand how toxic algal blooms can harm wildlife.

The research program known as HERA, or Health and Environmental Risk Assessment, examines how diseases affecting dolphins are related to potential environmental stressors and how they serve as an early warning system of changes that could affect animal and human health. Initial findings are expected in the coming weeks.

For over two weeks, a team of more than 50 specialists performed health assessments on more than 25 dolphins. The samples collected included blood, blubber and skin biopsies for genetics, as well as all the metabolic and physiological data like respiration rate, heart rate and general health parameters. Fire was specifically collecting gastric samples because of his focus on biotoxins make their way into the food web for these animals.

The biological samples collected from the dolphins will be analyzed, and the data will then be added to the HERA database.

Fire, who helped veterinarians assemble and assess the dolphins, had the rare opportunity to gather samples from healthy animals.

“The data we have for biotoxins in live marine mammals from the Indian River Lagoon are inconclusive, so this was a way to get additional data,” he said.

Fire wants to use the data as a baseline to gauge when toxin levels become fatal during an algal bloom.

Under a federal permit, HERA program researchers have safely examined and released more than 350 , primarily from the Indian River Lagoon, since 2003. This year’s assessments were in the northern IRL, where there’ve been three unusual mortality events, or unexpected strandings in which significant numbers of dolphins died.

“Dolphins are like the proverbial canaries in a coal mine,” said Gregory Bossart, V.M.D., Ph.D., chief veterinary officer and senior vice president at Georgia Aquarium. “Understanding their health and determining what impacts them is important because they can serve as indicators of ocean health, giving insight into larger environmental issues that may also have implications for .”

Fire added, “If animal is deteriorating over a trend of several years because their environment is deteriorating, what does that mean for humans? We share the same habitat, we eat a lot of the same food, we use the same waters.”

Since the internationally renowned HERA program began, it has documented emerging disease, antibiotic resistant bacteria, immune dysfunction and high levels of some toxins, including mercury in IRL dolphins

This article originally appeared on the phys website.

7

Updates direct to your Email

Enter your email address to receive notifications of new posts and opportunities by email.

Join 7,243 other subscribers

Post categories